Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-term Maintenance Study.
Waqqas AfifRamesh Pulendran ArasaradnamMaria T AbreuSilvio DaneseWilliam J SandbornYe MiaoHongyan ZhangRemo PanaccioneTadakazu HisamatsuEllen J ScherlRupert W L LeongDavid S RowbothamLaurent Peyrin-BirouletBruce E SandsColleen MaranoPublished in: The American journal of gastroenterology (2023)
The long-term efficacy of ustekinumab maintenance in patients with UC was confirmed through 4 years. No new safety signals were observed.
Keyphrases